| 股票 | 申万二级 | PE | 前瞻PE | PEG | PB | 股息率 | 分红率 | 毛利率 | 固定资产 | 债/EBITDA | FCF/市值 | 营收3年 | 去年 | YTD | 近一年 | 回撤 | 波动 | 市值亿 ▴ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 本立科技 301065 | 化学制药 | 26.4 | — | — | 1.50 | 1.5% | 32% | 17% | 37% | 0.0 | -3.8% | -6% | +15% | -7% | -18% | -32% | 30% | 21 |
| 中哲精化 000953 | 化学制药 | 640.9 | — | — | 14.42 | — | — | 15% | 49% | — | 0.8% | +4% | +29% | -16% | -20% | -39% | 37% | 22 |
| 浙江震元 000705 | 医药商业 | — | — | — | 1.24 | — | 42% | 19% | 38% | 4.1 | -2.2% | -18% | +15% | -20% | -25% | -43% | 29% | 24 |
| 南卫股份 603880 | 医疗器械 | — | — | — | 17.53 | — | — | 9% | 50% | — | 1.1% | +3% | +43% | +55% | +44% | -34% | 49% | 28 |
| 冀衡医药 002742 | 化学制药 | — | — | — | 19.75 | — | — | 16% | 41% | — | -3.6% | -24% | +74% | -5% | +44% | -35% | 74% | 29 |
| 澳洋健康 002172 | 医疗服务 | 95.1 | — | — | 16.11 | — | — | 14% | 41% | 6.6 | -0.2% | -4% | +27% | +6% | -1% | -40% | 47% | 32 |
| 和元生物 688238 | 医疗服务 | — | — | — | 3.22 | — | — | -7% | 65% | — | -4.4% | -3% | +35% | -3% | -24% | -39% | 55% | 42 |
| 蓝帆医疗 002382 | 医疗器械 | — | 12.4 | 0.83 | 0.84 | — | — | 16% | 32% | 3.2 | 3.1% | +5% | +9% | +6% | -9% | -41% | 37% | 60 |
| 宏源药业 301246 | 化学制药 | 25.9 | 9.4 | 0.14 | 1.58 | 0.3% | 22% | 19% | 39% | 1.2 | -3.0% | -2% | +86% | -27% | +17% | -48% | 62% | 73 |
| 创新医疗 002173 | 医疗服务 | — | — | — | 4.92 | — | — | 7% | 58% | — | -0.7% | +3% | +170% | -14% | -23% | -57% | 66% | 81 |
| 国际医学 000516 | 医疗服务 | — | — | — | 2.79 | — | — | 8% | 79% | 7.7 | 11.3% | +14% | -19% | -6% | -26% | -38% | 38% | 91 |
| 富祥股份 300497 | 化学制药 | 76.4 | 15.2 | 0.69 | 4.17 | 0.3% | — | 17% | 48% | 4.2 | -0.4% | -10% | +82% | +21% | +68% | -34% | 66% | 98 |
点表头排序。市值单位亿元;去年/YTD 为前复权涨幅;债/EBITDA = 有息负债 ÷ EBITDA。